Lenovo is just copying their betters at the NSA: Infect the machines of others and when caught, deny it. Sadly, this business model will probably work for them.
Most Americans are apathetic. Of those of us not apathetic, those opposed to the widespread espionage of the three letter agencies are in the minority.
It's been heartbreaking watching the American reputation decline worldwide while also watching the inverse rise of the amoral and unrepentant technocrat here in America. It's a Golden Age for technology and a Dark Age for culture.
I don't know what's more disturbing: the fact that US government does this with impunity or the fact that a sizable group of technically competent citizens defends it.
This is a good place for this, one of my favorite quotes from the century before last:
"Next in importance to personal freedom is immunity from suspicions, and jealous observation. Men may be without restraints upon their liberty: they may pass to and fro at pleasure: but if their steps are tracked by spies and informers, their words noted down for crimination, their associates watched as conspirators, who shall say that they are free? Nothing is more revolting to Englishmen than the espionage which forms part of the administrative system of continental despotisms. It haunts men like an evil genius, chills their gaiety, restrains their wit, casts a shadow over their friendships, and blights their domestic hearth."
The freedom of a country may be measured by its immunity from this baleful agency. Rulers who distrust their own people, must govern in a spirit of absolutism; and suspected subjects will be ever sensible of their bondage."
The Constitutional History Of England Vol II(1863), pg. 288 [0]
"The best propaganda is that which, as it were, works invisibly, penetrates the whole of life without the public having any knowledge of the propagandistic initiative." -Goebbels
What a pantload. This order is about DHS "legally" having access to corporate data instead of the usual method of tapping network pipes while also protecting those corporations from lawsuits.
> The FDA does not typically notify journals when a site participating in a published clinical trial receives an OAI inspection, nor does it generally make any announcement intended to alert the public about the research misconduct that it finds. The documents the agency discloses tend to be heavily redacted. As a result, it is usually very difficult, or even impossible, to determine which published clinical trials are implicated by the FDA’s allegations of research misconduct.